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Abstract
We used the Transwell system to select highly invasive
cell lines from minimally invasive parent cells, and we
compared gene expression in paired cell lines with high
and low invasive potentials. Axl was relatively over-
expressed in the highly invasive cell lines when
compared with their minimally invasive counterparts.
However, there is only limited information about the
role of Axl in cancer invasion. The biologic function
of Axl in tumor invasion was investigated by over-
expression of full-length Axl in minimally invasive cells
and by siRNA knockdown of Axl expression in highly
invasive cells. Overexpression of Axl in minimally inva-
sive cells increased their invasiveness. siRNA reduced
cell invasiveness as Axl was downregulated in highly
invasive cells. We further investigated the protein ex-
pression of Axl by immunohistochemistry and its cor-
relation with clinicopathologic features. Data from a
study of 58 patient specimens showed thatAxl immuno-
reactivity was statistically significant with respect
to lymph node status (P < .0001) and the patient’s
clinical stage (P < .0001). Our results demonstrate that
Axl protein kinase seems to play an important role in the
invasion and progression of lung cancer.
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Introduction
Tumor invasion and metastasis are the most challenging
problems faced by oncologists. Although studies have fo-
cused on these issues, no major breakthrough has been
made in preventing tumor invasion and metastasis. In order
to achieve invasion andmetastasis, a cancer cell must break
away from its tumor and invade tissues in either the circu-
latory system or the lymphoid system, which then carries it
to a new location. These processes require a cadre of mo-
lecular and cellular alterations that enable cells to circum-
vent normal growth control mechanisms and to manipulate
their local environment [1]. To elucidate the mechanisms re-
quired for the invasion and metastasis of human cancers,
comparative studies of biologic behavior and genetic status
among clonally related cell lines with different metastatic poten-
tials may prove helpful [2].
Axl, also calledUFO,ARK, andTyro7,was originally identified
as a transforming gene in human leukemia [3–5]. The 894–
amino-acid human protein has a mass of 140 kDa, with roughly
equal distribution of amino acids on either side of the plasma
membrane. The ligandofAxl,Gas6 protein, is so namedby virtue
of the initial finding that the gene (growth arrest–specific gene 6)
that encodes the protein is highly expressed in growth-arrested
cells [6,7]. The biologic function of Axl/Gas6 in normal and ma-
lignant cell biology has not been completely elucidated, but
appears to be complex. For example, in noncancer cells, Axl
prevented serum deprivation–induced cell death and played a
role in cell proliferation [8–11]. Axl overexpression has been
demonstrated in breast, colon, and thyroid cancer cell lines and
in melanoma cells [12–15], and the function of Axl in tumors
was suggested to be involved in cell cycle reentry, survival, and
cell transformation (tumorigenesis) [16–18]. Nonetheless, there
is limited information about the role of Axl in cancer invasion
and metastasis.
Recent studies have provided some information on Axl in
tumor invasion and metastasis. Jacob et al. [19] analyzed the
expression of Axl in prostate cancer cells and found that it
was highly expressed in metastatic DU145 cells compared to
normal prostate cells and the prostatic carcinoma cell line.
Furthermore, Axl was expressed at higher levels in metastatic
tumors than in normal tissues or primary tumors [20]. Thus, Axl
may be implicated in cancer invasion and metastasis. The
present study was undertaken to isolate panels of cell lines
with different invasion potentials and to compare their gene
expression. The involvement of Axl in cancer invasion and
progression was examined.
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Materials and Methods
Cell Culture, Patients, and Tissues
Human lung adenocarcinoma cell lines CL1-0 and CL1-5
are minimally and highly invasive sublines that were selected
from the clonal cell line of human lung adenocarcinoma [2].
The other human cancer cell lines were obtained from the
American Type Culture Collection (Manassas, VA) and cul-
tured as previously described [21]. The cells weremaintained
in RPMI 1640 supplemented with 10% fetal bovine serum,
100 U/ml penicillin, and 100 mg/ml streptomycin. Cells were
incubated in a humidified atmosphere containing 5% CO2
at 37jC. The media were changed three times per week.
The cells were free ofMycoplasma contamination during the
study period. Specimens were obtained from 50 paraffin-
embedded lung adenocarcinomas that had been collected in
the Department of Pathology, Tri-Service General Hospital
(Taipei, Taiwan). For each case, a representative paraffin
block that contained both tumor and benign tissues was
selected. Serial sections were then cut for hematoxylin and
eosin (H&E) staining and experimental studies.
Selection Procedure
Selection of highly invasive subpopulations from parent
cell lines HT1197 and A59 was performed using a Transwell
system (6.5 mm diameter, 8 mm pore size with polycarbonate
membrane; Corning Costar, Acton, MA). Briefly, Transwell
inserts were coated with Matrigel Basement Membrane
Matrix (BD Biosciences, Bedford, MA). Cells were resus-
pended in RPMI 1640 containing 10% NuSerum (BD Bio-
sciences) and seeded into the wells. Following incubation for
24 to 72 hours at 37jC, the inserts were removed. The cells
that invaded through the membranes and attached to the
lower well were harvested and expanded for second-round
selection. As the serial selection of higher invasiveness cells
continued up to the fourth generation, the sublines of cells
were designated as HT1197-4 and A59-4.
Microarray Analysis
Microarraymembranes containing 9600 cDNA sequences
were generously provided by Dr. Konan Peck (Institute of
Biomedical Sciences, Academia Sinica, Taipei, Taiwan).
Single-color detection and image analysis were performed
as previously described [22]. The microarray image was digi-
tized using a drum scanner (ScanView, Foster City, CA);
image analysis and spot quantification were performed as
described previously [23]. Program isolates differentially ex-
pressed genes by measuring the integrated density of each
spot, performing regression analysis on integrated density
data, and locating statistical outliers as differentially ex-
pressed genes. Genes whose expression profiles correlated
either positively or negatively with the invasiveness of cell
lines were identified.
In Vitro Invasion Assay
The invasion ability of tumor cells was examined using
24-well culture insert-based assays (BD Biosciences, Frank-
lin Lakes, NJ). The culture insert, with 8 mm pore size, was
precoated to a density of 30 mg/insert of Matrigel Basement
Membrane Matrix (BD Biosciences). Cells were suspended
in medium containing 10% NuSerum, and 2.5  104 cells
were added onto the insert. After incubating for 24 hours at
37jC, the cells that invaded or migrated through the Fluoro-
Blok membrane were stained with propidium iodine, and
fluorescence images were taken. The invasive cells were
then counted with Analytical Imaging Station software pack-
age (Imaging Research, Ontario, Canada). The samples
were plated in triplicate or quadruplicate, and the experiment
was repeated at least twice.
RNA Extraction, Reverse Transcription Polymerase Chain
Reaction (RT-PCR), and Real-Time PCR
Total cellular RNAwas extracted, purified, and converted to
cDNA with the use of oligo d(T)12–18 primers to preserve the
relative mRNA profile and to produce a template suitable for
PCR. The PCR primers used were: Axl sense 5V-AACCT
TCAAC TCCTG CCTTC TCG-3V and antisense 5V-CAGCT
TCTCC TTCAG CTCTT CAC-3V. Primers specific for a seg-
ment of GAPDH (sense 5V-AGGGG TCTAC ATGGC AACTG-
3V and antisense 5V-CGACCACTTTGTCAAGCTCA-3V) were
used to confirm cDNA integrity and normalization of cDNA
yields. In the PCR step, 50 pmol each of sense and antisense
primer was used. Standard PCR amplification conditions con-
sisted of a hot start at 94jC for 5 minutes, followed by 94jC
for 30 seconds, 55jC for 30 seconds, and 72jC for 1 minute
for 30 cycles, with a final amplification at 72jC for 10 minutes.
The DNA was visualized using ethidium bromide staining,
and band density was determined with a densitometer. Real-
time PCR from this cDNA product was performed with the use
of a thermocycler with continuous fluorescence-monitoring
capabilities (Roche, Mannheim, Germany). The SYBR Green
1 LightCycler reverse transcriptase (RT) PCR kit (Roche) was
used for PCR amplification under conditions recommended
by the manufacturer.
Protein Extraction and Western Blot Analysis
Cells were lysed in a lysis buffer (50mMTris–HCl, 150mM
NaCl, 1 mM EGTA, 1% NP-40, 1 mM NaF, 1 mM Na3VO4,
1 mM PMSF, and 1 mg/ml each of aprotinin and leupeptin,
pH 7.4) for 20minutes at 4jC, and the concentration of protein
in each cell lysate was measured using a commercial bicin-
choninic acid kit (Pierce, Rockford, IL). A 50-ı`g sample of
each lysate was subjected to electrophoresis on 8% sodium
dodecyl sulfate polyacrylamide gel. Proteins were then trans-
ferred to nitrocellulose membrane and immunoblotted with
antibodies. Detection was performed using the Western blot
reagent ECL, and chemiluminescence was exposed onto
Kodak X-Omat film (Kodak, Chalon/Paris, France).
Construction of Full-Length Human Axl
and Cell Transfection
HumanAxl cDNAwas amplified by RT-PCRwith sense 5V-
CCCAA GCTTG GAAAG TTTGG CACCC ATG-3V and anti-
sense 5V-CCCAA GCTTG GTTGT CTCAG GCACC ATC-3V.
The resulting 2698-bp PCR product was digested withHindIII
restriction enzymes and subcloned into the mammalian
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expression vector pCMV-Tag 2A (Stratagene, La Jolla, CA).
Cell transfection was performed using Lipofectamine 2000
(Invitrogen, Carlsbad, CA) and subcultured into selective
media containing 1 mg/ml G418 (Invitrogen).
siRNA
Double-stranded siRNA targeting Axl (accession no.
NM-021913) was synthesized using Silencer siRNA Con-
struction Kit (Ambion, Austin, TX), as recommended by the
manufacturer. Briefly, single-stranded gene-specific sense
and antisense RNA oligomers were synthesized through
in vitro transcription using T7RNApolymerase. For annealing
of siRNA, sense and antisense single-stranded RNA oligo-
mers were mixed and incubated at 37jC overnight. siRNA
was ethanol-precipitated and resuspended in nuclease-
free water. The integrity and quantification of the siRNA
were confirmed by gel electrophoresis and measured at
260-nm absorbance. Transfection of four pooled siRNA du-
plexes for the targeting of any endogenous Axl gene was
performed using TransIT-TKO Transfection Reagent (Mirus,
Madison, WI) at a final concentration of 20 nM. Cells were
transfected twice at 3-day intervals and collected 72 hours
after the second transfection. Specific silencing of the tar-
geted gene was confirmed by RT-PCR and Western blot
analysis. Mock transfection with transfection reagent alone
served as the control.
Immunohistochemistry and Assessment of Axl Expression
Specimens from the paraffin blocks were cut into 5-mm
sections. The sections were routinely stained with H&E for
histologic diagnosis, and additional sequential sections were
selected for immunohistochemical studies. Sections were
dewaxed and subjected to microwave antigen retrieval.
Endogenous peroxidase activity and nonspecific binding were
blocked by incubation with 3% hydrogen peroxide and non-
immune serum, respectively. Slides were then incubated
sequentially with rabbit anti–human Axl antibody (Santa Cruz
Biotechnology, Santa Cruz, CA) at 1:100 for 60 minutes and
peroxidase-labeled secondary antibody for 10 minutes. Di-
aminobenzidine hydrochloride (Dako, Carpinteria, CA) was
then added in order to localize positive staining sequentially by
light microscopy. For negative control experiments, primary
antibodies were omitted or replaced with an irrelevant anti-
body, mouse immunoglobulin G1 (Dako). Sections were coun-
terstained with hematoxylin and coverslipped. Using a
semiquantitative scale described previously [24], staining re-
sults were classified into positive (>25%) and negative (<25%)
categories according to the percentage of immunostaining-
positive cells. Immunostaining results were evaluated by
two investigators (Y.S.S. and H.S.L.) without prior knowledge
of the tumor’s histopathologic features and the patient’s clini-
cal status. TNM classification and staging were in accordance
with the designated system of the World Health Organization.
For further analysis, tumor stage was subdivided into two
groups: 1) localized tumors: stages 0, IA, and IB; and 2) ad-
vanced tumors: stages IIA, IIB, IIIA, IIIB, and IV.
Statistical Analysis
Immunohistochemistry results were analyzed using chi-
square analysis. The correlation between Axl and various
disease parameters was determined using Fisher’s exact
test. Differences were considered significant when P < .05.
Results
Selection of Highly Invasive Cancer Cell Lines from
Minimally Invasive Parent Cells
CL1-0 andCL1-5were previously establishedwithminimally
and highly invasive abilities, respectively, in our laboratory [2].
Figure 1. Establishment of cell lines with high and low invasion ability. (A) Lung cancer CL1-0, bladder cancer HT1197, and ovary cancer A59 cells were subjected
to repeated selection procedures and denoted CL1-5, A59-4, and HT1197-4, respectively. Their invasion abilities were evaluated using Matrigel-coated Transwell
membranes. (B) Gene expression analysis revealed that Axl expression was significantly different in highly and minimally invasive cell lines.
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We used parental cells A59 and HT1197 to select highly
invasive cancer cell lines A59-4 and HT1197-4 as the cells
that invaded the Matrigel four times. Both cell lines showed
morphologic characteristics of their epithelial cell origin, with
positive staining of cytokeratin (data not shown). We further
measured the difference in invasiveness associated with
these cell lines. As shown in Figure 1A, the invasive ability
of the sublines A59-4 and HT1197-4 increased three- to four-
fold compared to their parent cell lines. The invasive poten-
tials of these two cell lines were continuously maintained in
culture throughout this study.
Axl Expression in Highly and Minimally Invasive Cell Lines
To compare gene expression differences in highly and
minimally invasive cell lines, cDNA microarrays were used to
examine their gene expression profiles between paired cell
lines. Among these genes that displayed more than a two-
fold expression change, we found that Axl was relatively
overexpressed in the three highly invasive cell lines com-
pared to their minimally invasive counterparts (Figure 1B). In
order to confirm this finding, the association of Axl expres-
sion and invasive potential was examined in additional hu-
man cancer cell lines. Regardless of tissue origin, AxlmRNA
expression was relevant to cell-invasive ability (Figure 2,
A andB). Similar findings were seen when protein expression
was evaluated (Figure 2, A and C).
Inhibition of Invasiveness by Axl siRNA
If Axl is important in regulating cell invasion, then
changes in Axl expression should affect cell invasiveness.
We performed a gene-silencing experiment utilizing double-
stranded siRNA to silence the Axl gene in the highly invasive
cell lines. Cancer cells were transfected with the siRNA and,
after 3 to 7 days of transfection, RNA was extracted from
both control and transfected cell lines. RT-PCR and Western
blot analysis revealed a significant decrease in Axl gene
expression in the siRNA-transfected cells compared to
the control cells (Figure 3, A and B). Then, we evaluated
the effect of siRNA/Axl in cell invasion. Concomitantly, trans-
fection of siRNA/Axl reduced cell invasion ability (Figure 3C).
Axl Transfection Enhances Cell-Invasive Ability
A full-length Axl expression vector was constructed and
transfected to the minimally invasive cancer cell line CL1-0.
The vector-alone transfectant CL1-0/neo and the Axl trans-
fectant CL1-0/Axl-p were obtained. Stable Axl-overexpressing
single cell clones CL1-0/Axl-10 and CL1-0/Axl-15 selected
from CL1-0/Axl-p were subjected to further investigation. Axl
expression was increased in overexpression clones relative
to wild type and vector control cells both in RNA and protein
Figure 2. Axl expression is relevant to cell invasion ability. Several cell lines
from different tissues (colon, lung, bladder, and breast) were investigated for
their invasion abilities (A). Axl RNA expression (B) and Axl protein levels (C)
were also analyzed relative to their invasiveness.
Figure 3. Double-stranded siRNA/Axl downregulation of Axl expression
accompanied the reduction of cell invasion ability. The highly invasive cell line
CL1-5 was transfected with siRNA/Axl. Total RNA was extracted and ana-
lyzed by RT-PCR using primers specific to Axl and GAPDH (A). Cells col-
lected on the indicated day (RNAi-3, 3 days; RNAi-7, 7 days) were lysed, and
the expression of Axl was analyzed by Western blot analysis using anti-Axl or
anti-tubulin antibodies (B). Invasion assays showed reduced cell invasiveness
due to Axl knockdown compared to control (mock) cells (C).
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levels (Figure 4, A and B). When cell invasiveness was
examined using the standard Transwell assay, more Axl-over-
expressing cells invaded the bottom chamber than did the
control-vector-alone–expressing cells (CL1-0/neo) and origi-
nal cells (CL1-0) (Figure 4C). As Axl is proposed to be involved
in cell proliferation, it is important to ensure that increased
cell invasion in these assays is not due to higher growth
rates of Axl-overexpressing cells. To exclude this possibility,
the growth rate of Axl-overexpressing cell lines was mea-
sured, and no significant difference to that of the controls
was found (data not shown).
Immunohistochemistry in Tumor Tissues
To further examine whether Axl expression relates
to disease features of cancer, we compared Axl expression
in 58 lung adenocarcinoma patients by immunostaining.
Immunoreactivity of Axl was detected in vascular structures
(which acted as positive internal control for analysis), as
well as in lung cancer cells (Figure 5). In cancer tissue, posi-
tive and negative Axl protein expressions were observed in
28 of 58 (48.3%) and in 30 of 58 (51.7%) cases, respec-
tively. Correlations between the incidence of positive immuno-
reactivity for Axl and the clinicopathologic features of lung
adenocarcinoma are shown in Table 1. Axl protein expres-
sion was significantly associated with lymph node involve-
ment (P < .0001) and clinical stage (P < .0001).
Discussion
Tumor invasion is a complex process [25] by which malig-
nantly transformed cells detach from the primary tumor,
migrate, and cross structural barriers, including basement
membranes and surrounding stromal collagenous extracel-
lular matrix [25]. However, our knowledge regarding the
mechanism by which tumorigenic cells initiate further in-
vasive and metastatic processes is limited. In an effort to
identify genes that are relevant to invasive and metastatic
spread, it is advantageous to study variants of the same
tumor that differ in their invasion and metastasis patterns.
Comparison of phenotypic differences associatedwith the dif-
ferential invasive and metastatic abilities of tumor cells may
enhance our understanding of the mechanisms underlying
Figure 4. Axl transfection of minimally invasive cell lines resulted in increased
cell invasion in minimally invasive cell lines. CL1-0/Axl-p (a mixed population
and stable clone), CL1-0-Axl-10, and CL1-0-Axl-15 showed increased Axl
RNA (A) and protein expressions (B) compared to control cells CL1-0 and
CL1-0-neo (vector alone). Cell invasiveness was also increased in Axl-
transfected cells compared to the control cells (C).
Figure 5. Axl expression in vascular (A) and cancer tissues with negative (B)
and positive staining (C).
Table 1. Correlation of Axl Expression with Clinicopathologic Features of
Patients with Lung Cancer.
Clinicopathologic Features Axl Expression
Negative (n = 30)* Positive (n = 28)* P value
Gender
Male (n = 31)* 15 16 .389
Female (n = 27) 15 12
Size (cm)
V3.0 (n = 21) 12 9 .364
>3.0 (n = 37) 18 19
Lymph node involvement
No (n = 29) 23 6 <.0001
Yes (n = 29) 7 22
Differentiation
Well (n = 13) 8 5 .380
Moderate (n = 29) 16 13
Poor (n = 16) 6 10
Staging
Localized (n = 20) 17 3 <.0001
Advanced (n = 38) 13 25
*Data are numbers of cases. The expression of Axl is classified as positive if
>25% of tumor cells are stained and as negative if <25% of cancer cells are
stained.
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cancer metastasis. Therefore, the ultimate goals of the
present study were to identify potential markers that could
predict the possibility of tumor invasion and metastasis.
Previously, our laboratory isolated the highly invasive cell line
CL1-5 from the lung cancer parent cell line CL1-0 using a
Transwell chamber [2]. This in vitro selection process pro-
vides a useful approach to isolating cell variants with different
degrees of malignancy, which can be used to assess prop-
erties associated specifically with tumor invasion and metas-
tasis. By similar application with the selection procedure in a
Transwell chamber, the present study further established
sets of cell lines from HT1197 and A59 with different invasive
capacities. Using these materials, the mechanisms of inva-
sion and metastasis of cancer could be further investigated.
We were interested in identifying common genes contrib-
uting to differences in tumor invasion and metastasis. There-
fore, we compared gene expressions among these highly
and minimally invasive cell lines, and Axl was identified.
Axl is a known proto-oncogene in the tyrosine kinase family
whose exact role in the neoplastic process has not been
fully elucidated. The suggestion that Gas6/Axl may be impor-
tant for invasion and metastasis came from clinical studies.
Craven et al. [20] isolated a series of DNA fragments coding
for tyrosine kinases that were expressed in a metastatic
human colon tumor and subsequently analyzed for their
expression patterns at the protein level in human tumors.
Axl receptor tyrosine kinase was expressed at levels in a
peritoneal metastatic nodule that were 10-fold higher than
those in other normal and malignant tissues. Jacob et al. [19]
used a modified differential display PCR protocol for isolating
3V restriction fragments of cDNA specifically expressed or
overexpressed in the metastatic prostate carcinoma cell line
DU145. In the present study, we further demonstrated that
the expression of Axl is associated with lung tumor invasion
ability. Taken together, these results suggest that Axl plays an
important in tumor invasion and progression.
The involvement of Axl in tumor invasion was observed
using overexpression and siRNA knockdown expression.
Interestingly, growth kinetics of Axl-transfected cells and
growth rates showed no differences between Axl-transfected
and control cells. Similar results also were demonstrated in
the study of Wimmel et al. [26] on transfected Axl-negative
lung cell lines with expression vectors containing wild-type
Axl, and they found that no growth occurred in any of the
transfected cell lines. Thus, it is possible that the function of
Axl is cell- and tissue-specific and may depend on the bio-
logic context in which it is expressed. In addition, our staining
results in cancer tissues demonstrated that upregulation
of Axl significantly correlated with tumor progression. Al-
though the expression of Axl was not associated with tumor
size and differentiation, it significantly correlated with cancer
lymph node metastases (Table 1). These results were con-
sistent with previous findings that Axl expression was asso-
ciated with malignant phenotypes from patients with myeloid
leukogenesis [16,20]. Patients with acute myeloid leukemia
who had high Axl levels were found to have a worse prog-
nosis for progression-free and overall survival [27]. Thus,
tumor staining data confirmed our observations in cell cul-
tures and further extended the role of Axl in tumor invasion
and metastasis.
In conclusion, our study demonstrates that Axl expression
appears to be involved in cancer invasion. This result shows
that Axl expression is involved in tumor progression and that
protein expression analysis of Axl may be a biologic marker
of tumor progression for patients with lung cancer. Further
investigations will be required to determine the intrinsic
signaling mechanisms by which Axl modulates cancer cell
invasion and cancer progression.
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